Loargys

Active Ingredient(s): Pegzilarginase-nbln
FDA Approved: * February 23, 2026
Pharm Company: * IMMEDICA PHARMA AB
Category: Genetic Disorders
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Loargys 2 mg/.4ml Intravenous; Subcutaneous Injection
NDC: 81583-102
Labeler:
Immedica Pharma Us Inc.
Loargys 5 mg/ml Intravenous; Subcutaneous Injection
NDC: 81583-105
Labeler:
Immedica Pharma Us Inc.